Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories
Connor Bargar, Chiara Maria Giulia De Luca, Grazia Devigili, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 407
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
Ayami Okuzumi, Taku Hatano, Gen Matsumoto, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1448-1455
Open Access | Times Cited: 154
Multiple system atrophy
Werner Poewe, Iva Stanković, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 149
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies
G. Bellomo, Chiara Maria Giulia De Luca, Federico Paolini Paoletti, et al.
Neurology (2022) Vol. 99, Iss. 5, pp. 195-205
Closed Access | Times Cited: 86
α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
Anna Grossauer, Greta Hemicker, Florian Krismer, et al.
Movement Disorders Clinical Practice (2023) Vol. 10, Iss. 5, pp. 737-747
Open Access | Times Cited: 51
Initiation and progression of α-synuclein pathology in Parkinson’s disease
George K. Tofaris
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 4
Open Access | Times Cited: 65
Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: A systematic review and meta-analysis
Dallah Yoo, Ji-In Bang, Choonghyun Ahn, et al.
Parkinsonism & Related Disorders (2022) Vol. 104, pp. 99-109
Closed Access | Times Cited: 50
Combining skin and olfactory α-synuclein seed amplification assays (SAA)—towards biomarker-driven phenotyping in synucleinopathies
Anastasia Kuzkina, Jonas Rößle, A. Seger, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms
Nadia Stefanova, Gregor K. Wenning
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 6, pp. 334-346
Closed Access | Times Cited: 28
α-Synuclein seed amplification technology for Parkinson’s disease and related synucleinopathies
Claudio Soto
Trends in biotechnology (2024) Vol. 42, Iss. 7, pp. 829-841
Closed Access | Times Cited: 8
Enhanced quantitation of pathological α-synuclein in patient biospecimens by RT-QuIC seed amplification assays
Ankit Srivastava, Qinlu Wang, Christina D. Orrù, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 9, pp. e1012554-e1012554
Open Access | Times Cited: 7
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 10, pp. 100629-100629
Open Access | Times Cited: 20
Comparison of biospecimens for α‐synuclein seed amplification assays in Parkinson's disease: A systematic review and network meta‐analysis
Yuanchu Zheng, Siming Li, Yang Chen, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 12, pp. 3949-3967
Closed Access | Times Cited: 16
Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
Juan Huang, Xingxing Yuan, Lin Chen, et al.
Experimental Gerontology (2024) Vol. 187, pp. 112366-112366
Open Access | Times Cited: 7
Detection of α‐Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder
Yuanchu Zheng, Zhenwei Yu, Huihui Cai, et al.
Movement Disorders (2024) Vol. 39, Iss. 8, pp. 1300-1309
Open Access | Times Cited: 5
Advancing Parkinson’s diagnosis: seed amplification assay for α-synuclein detection in minimally invasive samples
Elizabeth Carrazana, Leonardo Montalbán-Gutiérrez, Pedro Chaná‐Cuevas, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access
Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
James A. Wiseman, Clinton Turner, Richard L. M. Faull, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
The Future of Seed Amplification Assays and Clinical Trials
Thomas Coysh, Simon Mead
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 27
Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Elena García‐Martín, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1263-1263
Open Access | Times Cited: 14
Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
Ilaria Linda Dellarole, Elena Vacchi, Iñigo Ruiz‐Barrio, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Integrative Analysis of Metabolome and Proteome in the Cerebrospinal Fluid of Patients with Multiple System Atrophy
Nimisha Pradeep George, Minjun Kwon, Yong Eun Jang, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 265-265
Open Access
Tau biomarkers for Neurodegenerative Diseases: current state and perspectives
Elena Vacchi, Iñigo Ruiz‐Barrio, Giorgia Melli
Parkinsonism & Related Disorders (2025), pp. 107772-107772
Closed Access
Amelioration of olfactory dysfunction in a mouse model of Parkinson’s disease via enhancing GABAergic signaling
Xingyang Liu, Ke Wang, Xianhua Deng, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Multidimensional biomarkers for multiple system atrophy: an update and future directions
Linlin Wan, Sudan Zhu, Zhao Chen, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers
Meghana Goolla, William P. Cheshire, Owen A. Ross, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top